We also market point-of-care tests for CRP on our Afinion and Nycocard systems, which is raised in bacterial infection and is also a marker of inflammation (often associated with infection). Our novel marker Heparin Binding Protein (HBP), which is associated with severe sepsis will be available in 2012. Information on all of these analytes is available in this section.
A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.
Axis-Shield's award winning point-of-care test system is designed for maximum simplicity coupled with laboratory accuracy and reliability for a number of key markers important for improved patient management.